BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TCL1A, P56279, 8115, ENSG00000100721, TCL1
6 results:

  • 1. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria.
    Larkin J; Weber J; Del Vecchio M; Gogas H; Arance AM; Dalle S; Cowey CL; Schenker M; Grob JJ; Chiarion-Sileni V; Márquez-Rodas I; Butler MO; Di Giacomo AM; Middleton MR; De la Cruz-Merino L; Arenberger P; Atkinson V; Hill A; Fecher LA; Millward M; Khushalani NI; Queirolo P; Long GV; Lobo M; Askelson M; Ascierto PA; Mandalá M
    Eur J Cancer; 2022 Sep; 173():285-296. PubMed ID: 35964471
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel long noncoding RNA PILRLS promote proliferation through tcl1a by activing MDM2 in Retroperitoneal liposarcoma.
    Shao Y; Zhang Y; Hou Y; Tong H; Zhuang R; Ji Z; Wang B; Zhou Y; Lu W
    Oncotarget; 2017 Feb; 8(8):13971-13978. PubMed ID: 28129655
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA; Schmidt RL; Patel JL; Medeiros LJ; Agarwal AM; Perkins SL; Salama ME
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.
    Kanamori M; Sano A; Yasuda T; Hori T; Suzuki K
    J Exp Clin Cancer Res; 2012 Nov; 31(1):100. PubMed ID: 23199169
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.
    Lorenzi L; Lonardi S; Petrilli G; Tanda F; Bella M; Laurino L; Rossi G; Facchetti F
    Hum Pathol; 2012 Feb; 43(2):209-15. PubMed ID: 21835430
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
    Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
    J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.